Increasing hepcidin levels may not only reduce iron overload but also partially control ineffective erythropoiesis in iron loading anemias. β-thalassemia is the most studied among these conditions (Casu et al., 2018; Gupta et al., 2018). The gene discussed is HAMP; the disease is dietary heme iron intake measurement.